The study of 20 enrolled patients (13 CF patients and 07 healthy patients with wild type CFTR) depicted LUM's enhanced effects over macrophage-phagocytic action against Pseudomonas aeruginosa (PA). The gene discussed is CFTR; the disease is cystic fibrosis.